We’re hiring an Event Sales Manager (Application closed)
Join our dynamic team! SwedenBIO is looking for an event sales manager to strengthen our sales activities and customer networks.

Join our dynamic team! SwedenBIO is looking for an event sales manager to strengthen our sales activities and customer networks.

Through the presidency in the EU-counsel during spring 2023, Sweden has the possibility to raise awareness of key topics that are crucial for a sustainable future and European competitiveness. We are delighted that the grand finale of the presidency has the flavour of life sciences.

On March 8, 2023 SwedenBIO launched the 2023 edition of the large, recurring mapping of the Swedish pharmaceutical pipeline.

On March 8, SwedenBIO launches the long-awaited 2023 edition of the large, recurring mapping of the Swedish pharmaceutical pipeline.

For cardiac patients with smaller bodies, current artificial hearts aren’t a viable solution. This could soon change as the startup Scandinavian Realheart is developing a smaller device with the help of a world-first simulator.

Digital therapeutics, the costs of gene and cell therapies, and a challenging financing situation were some of the highlights at J.P. Morgan’s annual healthcare meeting in San Francisco in January.

The big number of attendees and parallel activities make JP Morgan Healthcare week an exceptional event, which is why SwedenBIO offers support to Swedish companies looking to head west for new business opportunities.

This year’s SwedenBIO Award was given to the imaging technology company Antaros Medical, for their innovative imaging solution that aids the understanding of how medicines work in the human body.

At the SwedenBIO Summit December 6, our science relations manager Maja Neiman revealed some preliminary results from this year’s life science barometer. A comprehensive analysis will be published in the next edition of the The Swedish Drug Discovery and Development Pipeline report, coming in February 2023.

This year’s three finalists for the annual SwedenBIO Award exemplifies both the innovative power and the business acumen of Swedish companies.

How to create sustainable trading on the stock exchange
The life science sector is one of the strongest for listed small companies in Sweden. At the same time, the competition in the sector is fierce and it is necessary to work with the issues that affect share trading. A well-functioning share trading is important for creating growth in small and medium-sized companies.

Offer to you as an incubator company
Life for startup companies was not without challenges before the effects of the corona crisis hit, and the situation is now tough for many smaller companies. Now we want to contribute to building Sweden’s next generation of life science companies strong, for future export revenue and innovation power. Startup companies with up to four employees must be members of SwedenBIO for an annual fee of SEK 1,000.

Brännpunkt Life Science is an interview series in collaboration with DNB Sweden that focuses the magnifying glass on the intersection between innovation, capital and health. In the first part, we meet Adam Kostyal, European head of listing at Nasdaq, who looks at how the stock market year looked for the sector, talks about the impact of the pandemic and shares his predictions for the future.